How many drugs treat Ischemic Stroke?

Drug Landscape tracks 7 marketed treatments for Ischemic Stroke (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/ischemic-stroke.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Ischemic Stroke — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ischemic Stroke (disease) competitive landscape: 7 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

7 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Ischemic Stroke, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Radicava	EDARAVONE	Kk Bcj-94	edaravone		2017-01-01
Savaysa	edoxaban	Daiichi Sankyo Inc	Factor Xa Inhibitor	Coagulation factor X	2015-01-01
Activase	ALTEPLASE	Roche		Plasminogen	1996-01-01
PF-07976016 Formulation A	pf-07976016-formulation-a	Pfizer	Unknown	Unknown
3-Butylphthalide	Butylphthalide	CSPC Ouyi Pharmaceutical		Potassium channel subfamily K member 2
Radicava	Radicava	Shanghai Auzone Biological Technology Co., Ltd.		Polyunsaturated fatty acid lipoxygenase ALOX15
Activase	Activase	Medical College of Wisconsin		Plasminogen

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

CSPC Ouyi Pharmaceutical · 1 drug in Ischemic Stroke
Daiichi Sankyo Inc · 1 drug in Ischemic Stroke
Kk Bcj-94 · 1 drug in Ischemic Stroke
Medical College of Wisconsin · 1 drug in Ischemic Stroke
Pfizer · 1 drug in Ischemic Stroke
Pfizer Inc. · 1 drug in Ischemic Stroke
Roche · 1 drug in Ischemic Stroke
Shanghai Auzone Biological Technology Co., Ltd. · 1 drug in Ischemic Stroke

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Ischemic Stroke:

Cite this brief

Drug Landscape (2026). Ischemic Stroke — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/ischemic-stroke. Accessed 2026-06-10.

Ischemic Stroke full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing